Medicare Enrolled

Dr. Mamta Vijayvargiya, MD

Hematology & Oncology · Orange City, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
1061 MEDICAL CENTER DR STE 110, Orange City, FL 32763
3869177594
In practice since 2006 (20 years)
NPI: 1598733685 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vijayvargiya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vijayvargiya? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vijayvargiya

Dr. Mamta Vijayvargiya is a hematology & oncology in Orange City, FL, with 20 years in practice. Based on federal Medicare data, Dr. Vijayvargiya performed 1,086 Medicare services across 591 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vijayvargiya received a total of $18,355 from 64 pharmaceutical and/or device companies across 531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vijayvargiya is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 39% volume in FL$ $18,355 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,086
Medicare services
Top 39% in FL for hematology & oncology
591
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~54 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)227$89$200
Blood draw (venipuncture)214$8$18
Complete blood count (CBC) with differential209$8$30
Comprehensive metabolic blood panel102$10$18
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less87$46$235
Ferritin level test (iron stores)55$13$41
Office visit, established patient (20-29 min)39$66$150
Hospital follow-up visit, high complexity34$94$200
New patient office visit (45-59 min)31$117$485
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-324$20$63
Initial hospital admission, high complexity23$137$583
Nuclear medicine study from skull base to mid-thigh with ct scan15$1,098$5,000
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries15$401$900
Ct scan of abdomen and pelvis before and after contrast11$176$650
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.0% high complexity
2.4% medium
89.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$18,355
Total received (2018-2024)
Avg $2,622/year across 7 years
Top 27% in FL for hematology & oncology
64
Companies
531
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,288 (45.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,927 (37.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,141 (17.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,531
2023
$2,108
2022
$3,142
2021
$1,794
2020
$742
2019
$1,802
2018
$2,234

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,192
Karyopharm Therapeutics Inc.
$2,812
Novartis Pharmaceuticals Corporation
$2,266
Daiichi Sankyo Inc.
$1,412
PFIZER INC.
$906
BeiGene USA, Inc.
$766
Astellas Pharma US Inc
$695
Janssen Biotech, Inc.
$564
Celgene Corporation
$491
E.R. Squibb & Sons, L.L.C.
$468
Seagen Inc.
$418
Lilly USA, LLC
$397
GENZYME CORPORATION
$345
GlaxoSmithKline, LLC.
$313
Incyte Corporation
$257
COMSORT, Inc
$250
Seattle Genetics, Inc.
$238
Genentech USA, Inc.
$185
Athenex Pharmaceutical Division, LLC
$175
Exelixis Inc.
$158
Gilead Sciences, Inc.
$124
Takeda Pharmaceuticals U.S.A., Inc.
$123
Merck Sharp & Dohme LLC
$119
Kite Pharma, Inc.
$119
Bayer HealthCare Pharmaceuticals Inc.
$106
Amgen Inc.
$104
United Therapeutics Corporation
$100
ARRAY BIOPHARMA INC
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$94
JAZZ PHARMACEUTICALS INC.
$72
Mirati Therapeutics, Inc.
$61
Merck Sharp & Dohme Corporation
$59
Regeneron Healthcare Solutions, Inc.
$55
Bayer Healthcare Pharmaceuticals Inc.
$54
Alexion Pharmaceuticals, Inc.
$51
Epizyme, Inc.,
$51
Alnylam Pharmaceuticals Inc.
$49
Global Blood Therapeutics, Inc.
$43
TAIHO ONCOLOGY, INC.
$41
CTI BioPharma Corp.
$40
ABBVIE INC.
$34
Pharmacyclics LLC, An AbbVie Company
$33
Kyowa Kirin, Inc.
$30
EMD Serono, Inc.
$29
Deciphera Pharmaceuticals Inc.
$25
Stemline Therapeutics Inc.
$24
TerSera Therapeutics LLC
$23
MACROGENICS, INC.
$21
EISAI INC.
$21
Partner Therapeutics, Inc.
$20
SOBI, INC
$20
Pharmacosmos Therapeutics Inc.
$20
ADC Therapeutics America, Inc.
$19
Taiho Oncology, Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$17
ACCORD HEALTHCARE, INC.
$17
TOLMAR Pharmaceuticals, Inc.
$16
MorphoSys, US Inc.
$15
AbbVie Inc.
$15
Verity Pharmaceuticals Inc.
$14
EUSA Pharma (US) LLC
$13
Puma Biotechnology, Inc.
$13
Rigel Pharmaceuticals, Inc.
$12
INSYS Therapeutics Inc
$11
Top 3 companies account for 45.1% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · Aliqopa · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELIGARD · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Erleada · FASLODEX · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MARGENZA · MEKINIST · MONJUVI · Monoferric · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Revlimid · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SCEMBLIX · SHINGRIX · SOLIRIS · SPRYCEL · SUTENT · SYNDROS · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TIVDAK · TUKYSA · Tavalisse · Trelstar · Truqap · ULTOMIRIS · UNITUXIN · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Xtandi · Yescarta · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (45%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,690 per 100 Medicare services performed
Looking for a hematology & oncology in Orange City?
Compare hematology & oncologys in the Orange City area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
22
Per 100K population
3.9
County median income
$66,581
Nearest hospital
ADVENTHEALTH FISH MEMORIAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Vijayvargiya is a clinical cardiology specialist, with moderate Medicare volume, and mixed engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Vijayvargiya experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Vijayvargiya performed 227 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vijayvargiya receive payments from pharmaceutical companies?
Yes. Dr. Vijayvargiya received a total of $18,355 from 64 companies across 531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vijayvargiya's costs compare to other hematology & oncologys in Orange City?
Dr. Vijayvargiya's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vijayvargiya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →